Multiparametric MRI and [(18)F]Fluorodeoxyglucose Positron Emission Tomography Imaging Is a Potential Prognostic Imaging Biomarker in Recurrent Glioblastoma

PURPOSE/OBJECTIVES: Multiparametric advanced MR and [(18)F]fluorodeoxyglucose (FDG)-positron emission tomography (PET) imaging may be important biomarkers for prognosis as well for distinguishing recurrent glioblastoma multiforme (GBM) from treatment-related changes. METHODS/MATERIALS: We retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassanzadeh, Comron, Rao, Yuan James, Chundury, Anupama, Rowe, Jackson, Ponisio, Maria Rosana, Sharma, Akash, Miller-Thomas, Michelle, Tsien, Christina I., Ippolito, Joseph E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563320/
https://www.ncbi.nlm.nih.gov/pubmed/28868256
http://dx.doi.org/10.3389/fonc.2017.00178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563320/
https://www.ncbi.nlm.nih.gov/pubmed/28868256
http://dx.doi.org/10.3389/fonc.2017.00178

Ejemplares similares